baber/WOPTO huggingface dataset:
Patent EP-3939078-A1 (EP)
Inventor: LANDRU DIDIER
IPC: H01L21/762
Filed: 2020-02-26
Abstract: The invention relates to a method for transferring a useful layer to a carrier substrate, comprising the following steps: a) providing a donor substrate comprising a buried weakened plane, the useful layer being delimited by a front face of the donor substrate and the buried weakened plane; b) providing a carrier substrate; c) joining the donor substrate by its front face to the carrier substrate along a bonding interface to form a bonded structure; d) annealing the bonded structure to apply a weakening thermal budget thereto and bring the buried weakened plane to a defined level of weakening, said anneal reaching a maximum hold temperature; e) initiating a splitting wave in the buried weakened plane by applying a stress to the bonded structure, the splitting wave propagating along the buried weakened plane in a self-sustained manner to lead to the useful layer being transferred to the carrier substrate. Step e) is initiated when the bonded structure experiences a thermal gradient defining a hot region and a cool region of said bonded structure, the stress being locally exerted in the cool region, and the hot region experiencing a temperature lower than the maximum hold temperature.
Patent EP-3948385-A1 (EP)
Inventor: RICHARDS EVAN MARK
IPC: G02B27/62
Filed: 2020-02-17
Abstract: An alignment apparatus for a polarization device includes a polarizer subassembly for polarizing a light beam, a rotary support for rotatably supporting the polarization device in a path of the light beam downstream of the polarizer subassembly, an analyzer subassembly downstream of the rotary support for receiving the light beam propagated through the polarization device, and a photodetector array disposed downstream of the analyzer subassembly and extending along the width dimension of the light beam for detecting the light beam propagated through the analyzer subassembly. At least one of the polarizer or analyzer subassemblies includes a spatially variant polarization element having a polarization property varying along the width dimension of the light beam.
Patent EP-3939179-A1 (EP)
Inventor: SETHI YOGESH
IPC: H04B7/204
Filed: 2020-02-24
Abstract: A method to provide dedicated bandwidth, the method including: provisioning transmitters to transmit over a satellite link; generating, for each of the transmitters, a respective transmit signal using a common codeblock asynchronous Scrambled Code multiple access (A-SCMA) encoding for a respective information stream; transmitting, via the satellite link, the respective transmit signal from each of the transmitters; and varying a bandwidth rate of each of the respective transmit signals with a grant-free protocol, where the bandwidth rate of the respective transmit signals is less than or equal to a maximum system rate, the transmitting of at least two or more of the transmitters is at least partially concurrent, and each of the respective transmit signals is modulated at a common frequency over a common frequency band with a common polarization. The method reduces latency, jitter, and provides dynamic bandwidth allocation without allocation feedback.
Patent EP-3935794-A1 (EP)
Inventor: LECLAIR MARC
IPC: H04L45/02
Filed: 2020-03-31
Abstract: A network element (16) includes ingress optics (22) configured to receive a client signal; egress optics (30) configured to transmit packets over one or more Ethernet links (20) in a network (12); circuitry (26, 28) interconnecting the ingress optics (22) and the egress optics (30), wherein the circuitry is configured to segment an Optical Transport Network (OTN) signal from the client signal into one or more flows; and provide the one or more flows to the egress optics for transmission over the one or more of Ethernet links (20) to a second network element (18) that is configured to provide the one or more flows into the OTN signal.
Patent EP-3969493-A1 (EP)
Inventor: GOSSNER MATTHAEUS
IPC: C08G101/00
Filed: 2020-05-07
Abstract: Die Erfindung betrifft ein Verfahren zur Herstellung von Polyurethan-Weichschaum, wobei der Polyurethan-Weichschaum erhalten wird oder erhältlich ist durch Umsetzung einer Zusammensetzung enthaltend oder bestehend aus - einer Komponente A1 enthaltend oder bestehend aus mindestens einem gefüllten Polyol, - einer Komponente A2 enthaltend oder bestehend aus Verbindungen die gegenüber Isocyanaten reaktiv sind mit einer OH-Zahl gemäß DIN 53240-1, Verfahren ohne Katalysator, Juni 2013, von ≥ 20 bis < 100 mg KOH/g, und wobei die Komponente A2 kein gefülltes Polyol enthält - einer Komponente A3 enthaltend Wasser und/oder mindestens ein physikalisches Treibmittel, - einer Komponente A4 enthaltend Hilfs- und Zusatzstoffe, und - einer Komponente B enthaltend oder bestehend aus Di- und/oder Polyisocyanaten, wobei die Herstellung bei einer Kennzahl von 90 bis 140 erfolgt, dadurch gekennzeichnet, dass die Umsetzung unter Anwesenheit von - 0,5 bis 3 Gew.-Teilen, bezogen auf die Summe der Komponenten A1 und A2, eines organischen Harnstoffderivats als Komponente C erfolgt, das erhältlich ist oder erhalten ist durch Umsetzung von Harnstoff mit einem difunktionellen Amin, wobei das Amin ein zahlengemitteltes Molekulargewicht ermittelt nach DIN 55672-1 (März 2016), Teil 1, mit Gelpermeationschromatographie unter Verwendung von Polystyrolstandards und Tetrahydrofuran als Elutionsmittel von 200 bis 1000 g/mol aufweist. Des Weiteren betrifft die Erfindung einen Polyurethan-Weichschaum, insbesondere hochelastischen HR-Polyurethanweichschaum, erhältlich nach dem erfindungsgemäßen Verfahren, sowie die Verwendung dieses Polyurethan-Weichschaums zur Herstellung von Möbelpolsterungen, Textileinlagen, Matratzen, Automobilsitzen, Kopfstützen, Armlehnen, Sitzauflagen und Bauelementen.
Patent EP-3966347-A1 (EP)
Title: Method for the direct determination of fetal aneuploidies by non-invasive analysis of the fetal dna from maternal blood by means of dpcr
Inventor: DELLO RUSSO CLAUDIO
IPC: C12Q1/6883
Filed: 2020-04-20
Abstract: Method for determining the presence of fetal chromosomal aneuploidies by means of non-invasive analysis of the fetal DNA present in a sample of maternal blood previously taken from the pregnant woman, said method being characterized in that the DNA analysis is based on direct and quantitative cfDNA analysis using the ddPCR technique, said method providing for the use of a mathematical and bioinformatic analytical system which correlates the diagnostic result with the reciprocal ratios of the counts obtained for each chromosome of the fetal DNA.
Patent EP-3970294-A1 (EP)
Inventor: KHOSHNEVISAN MOSTAFA
IPC: H04L1/08
Filed: 2020-05-13
Abstract: PDSCH and PUSCH repetition enhancements are disclosed. A UE may determine configuration data (e.g., transmission parameters, and/or RV data) for PDSCH/PUSCH repetitions which are split across a slot transition within a slot or across a slot boundary based on a quantity of nominal repetitions indicated by a downlink control message (e.g., a downlink control information signal). A quantity of actual repetitions (e.g., splitting of one or more nominal repetitions) may be identified based on the quantity of nominal repetitions and slot configuration parameters. In some aspects, a UE determines a sequence of configuration data for nominal repetitions and generates a second sequence of configuration data for actual repetitions based on the sequence. In other aspects, a UE determines a single sequence of configuration data for actual repetitions based on the quantity of actual repetitions determined from the quantity of nominal repetitions indicated by the downlink control message.
Patent EP-3973583-A1 (EP)
Inventor: MILOBAR DANIEL G
IPC: H01M50/528
Filed: 2020-05-21
Abstract: Methods for electrically coupling electrode portions within electrochemical devices, and associated articles and systems, are generally described. In some cases, an electrically non-conductive layer is between multiple electrode portions that are to be coupled. In some cases, the method comprises penetrating the article to establish electrical coupling between the electrode portions previously separated by the electrically non-conductive layer.
Patent EP-3987041-A1 (EP)
Title: Novel mechanism to control rna virus replication and gene expression
Inventor: HOLM-VON LAER MEIKE DOROTHEE
IPC: C12N15/86
Filed: 2020-06-19
Abstract: The present invention relates to a novel mechanism to control RNA virus replication and gene expression using a conditional protease approach using a specific protease inhibitor for regulation. More specifically it relates to a single-stranded RNA virus, preferably of the order Mononegavirales, comprising a polynucleotide sequence encoding at least one protein essential for viral transcription and/or replication, a protease and a cleavage site for said protease. The protease can be inhibited using a protease inhibitor and hence the protease and the cleavage site for said protease form a regulatable switch. By changing the insertion site of the regulatable switch from an INTRA- to an INTER-molecular location in the at least one protein essential for viral transcription and/or replication, the effect of the protease inhibitor can be altered from an ON switch to an OFF switch. RNA virus may further encode a heterologous protein, the expression of which is then regulated by regulating viral activity. The ON switch may also be used in an RNA virus to directly regulate heterologous protein expression. Further provided are in vivo and in vitro uses of said virus with conditional viral activity or heterologous protein expression.
Patent EP-3986340-A1 (EP)
Inventor: OKEREKE MICHAEL
IPC: A61F2/915
Filed: 2020-06-22
Abstract: The disclosure provides a tubular stent comprising at least three primary elongate columns disposed around a circumference of the stent. The primary elongate columns substantially parallel to a longitudinal axis of the stent. The stent further comprises at least two non-linear struts disposed between each pair of circumferentially adjacent primary columns, wherein each strut extends between the circumferentially adjacent primary columns. The stent is configured to adopt a first, unexpanded configuration and a second, expanded configuration in which the stent has a greater diameter than in the first, unexpanded configuration.
Patent EP-3989840-A1 (EP)
Inventor: NAUWYNCK HANS
IPC: C12Q1/24
Filed: 2020-06-26
Abstract: The present invention is directed to a sampling device for the collection and isolation of a biological specimen from a sample or from a location. The sampling device comprises a swab tip and a support body wherein the support body has a hollow conformation with a first end and a second end and wherein said first end is in fluid connection with the internal surface of the swab tip. Typical for the present sampling device is that the swab tip comprises a filter material with a pore size that decreases from the external surface of the swab tip to the internal surface of the swab tip. The invention further also discloses the use of said sampling device and a method for the collection and isolation of a biological specimen.
Patent EP-3989852-A1 (EP)
Title: Fortified balloon inflation fluid for plasma system to disrupt vascular lesions
Inventor: MASSIMINI DANIEL FRANK
IPC: A61B18/26
Filed: 2020-06-18
Abstract: A catheter system (100) for imparting pressure (1016) to induce fractures at a treatment site (1014) includes a catheter (101 ), a fortified balloon inflation fluid (2201 ) and a first light guide (2204). The catheter (101) includes an elongate shaft (102) and a balloon (122) that is coupled to the elongate shaft (102). The balloon (122) can expand to a first expanded configuration (1004) to anchor the catheter (101 ) in position relative to the treatment site (1014). The fortified balloon inflation fluid (2201) can expand the balloon (122) to the first expanded configuration (1004). The fortified balloon inflation fluid (2201) includes a base inflation fluid (2203) and a fortification component (2202). The fortification component (2202) reduces a threshold for inducing plasma formation in the fortified balloon inflation fluid (2201) compared to the base inflation fluid (2203). The fortification component (2202) can include at least one of carbon and iron. The first light guide (2204) is disposed along the elongate shaft (102) and is positioned at least partially within the balloon (122). The first light guide (2204) is in optical communication with a light source (116) and the fortified balloon inflation fluid (2201 ). The light source (116) provides sub-millisecond pulses of a light to the first light guide (2204) so that plasma formation and rapid bubble (130) formation occur in the fortified balloon inflation fluid (2201 ), thereby imparting pressure waves (1016) upon the treatment site (1014).
Patent EP-3912171-A1 (EP)
Inventor: SHARGOTS SCOTT J
IPC: G21C3/33
Filed: 2020-01-10
Abstract: A nuclear fuel assembly for a nuclear reactor core including at least one fuel cartridge having a lattice structure including an outer wall defining an interior volume, at least one flow channel extending through the interior volume of the lattice structure, at least one lattice site disposed in the interior of the lattice structure; and at least one fuel compact disposed within a corresponding one of the at least one lattice site. A cross-sectional shape of the at least one fuel compact is the same as a cross-sectional shape of the corresponding one of the at least one lattice site.
Patent EP-4013616-A1 (EP)
Inventor: MELOTTI RENZO
IPC: B41F13/20
Filed: 2020-07-22
Abstract: A drum support assembly (30, 32) for a printing machine is presented. It comprises a drum support body (30a, 32a) having a bearing interface (30b, 32b) for a drum, a lower guide (34) supporting the drum support body (30a, 32a) at a lower end thereof, and an upper guide (36) supporting the drum support body (30a, 32a) at an upper end thereof. Additionally, a pre-tensioning unit (50) is provided pre-tensioning the drum support body (30a, 32a) against the lower guide (34) and/or the upper guide (36). Furthermore, a printing machine is described, comprising a drum and a drum support assembly (30, 32) as described above.
Patent EP-3980375-A1 (EP)
Title: Densified reduced graphene oxide and methods of production
Inventor: CHEN LIMENG
IPC: C08L7/00
Filed: 2020-06-04
Abstract: Methods for the production of densified granules of graphene oxide worm (rGOW) particles. Graphene oxide worms are combined with a liquid to produce densified granules of graphene oxide worms. The granules can be easily processed and can be incorporated into polymeric compositions such as elastomers. Also disclosed are masterbatch and composite materials made by combining the granules with a polymer.
Patent EP-4021883-A1 (EP)
Inventor: FISCHER KAI JÜRGEN
IPC: C07C69/96
Filed: 2020-08-06
Abstract: The present invention relates to a process for preparing an organic carbonate, comprising contacting carbon dioxide with an alcohol in the presence of water and a catalyst in a reaction zone resulting in the production of the organic carbonate, wherein the organic carbonate is continuously removed from the reaction zone.
Patent EP-4022740-A1 (EP)
Inventor: VAN VUGT HENRICUS ANTONIUS GERARDUS
IPC: H02J50/80
Filed: 2020-08-21
Abstract: A power transmitter (101) provides wireless power transfer to a power receiver (105) via a wireless inductive power transfer signal. The power transmitter (101) comprises transmitter coil (203) for generating the power transfer signal and a driver (201) generating a drive signal for this. A communicator (207) communicates with the power receiver (105) via a communication channel that does not use the power transfer signal as a communication carrier. A power loop controller (205) implements a power control loop by adapting a power level of the power transfer signal in response to power control error messages received from the power receiver (105). A generator (209) introduces a power level variation sequence to the power transfer signal and a validity detector (211) detects data received by the communicator (207) to be invalid data for the power transfer in response to a comparison of the power level variation sequence and power change requests of the power control error messages.
Patent EP-3932089-A1 (EP)
Inventor: CHO LEEG HYUN
IPC: H04R9/00
Filed: 2020-02-18
Abstract: Embodiments are disclosed of a speaker capable of producing multi-frequency-range sound using bar magnets, multiple diaphragms, and a shared planar voice coil. The planar voice coil is located between the bar magnets and translates a received electric signal into the kinetic energy that vibrates the diaphragms, thus reproducing multi-frequency range sound. In some embodiments, the speaker generates bi-directional sound.
Patent EP-3930835-A1 (EP)
Inventor: GOETZ JUERGEN
IPC: A61N7/00
Filed: 2020-02-27
Abstract: The present invention relates to methods of restoring cognitive function in aged individuals that do not exhibit a clinically detectable neurodegenerative disease. In one aspect, the present invention provides a method of improving cognitive function in an aged individual that does not have a neurodegenerative disease characterized by aggregation of a pathological protein, the method comprising or consisting of: applying a clinically safe level of acoustic energy to sites within a region of the brain, thereby saturating or substantially saturating the region with acoustic energy, thereby improving cognitive function in the aged individual.
Patent EP-3932890-A1 (EP)
Inventor: MATSUKAWA MICHIKO
IPC: C04B35/645
Filed: 2020-02-27
Abstract: A polycrystalline cubic boron nitride comprising 96% by volume or more of cubic boron nitride, wherein the cubic boron nitride has a dislocation density of 8 × 10<sup>15</sup>/m<sup>2</sup> or less, the polycrystalline cubic boron nitride comprises a plurality of crystal grains, and the plurality of crystal grains have a median diameter d50 of an equivalent circle diameter of less than 100 nm.
Patent EP-3946015-A1 (EP)
Title: Intraoperative clinical decision support system
Inventor: NANJI KAREN C
IPC: A61B5/375
Filed: 2020-03-27
Abstract: Systems and methods are provided for intraoperative real-time clinical decision support. A system includes a processor, a non-transitory computer readable medium, storing executable instructions, and an output device. An interface is configured to receive a first set of patient data in real-time from at least one sensor monitoring vital signals of a patient during a surgical procedure and a second set of patient data in real-time from an anesthesia machine during the surgical procedure. An input interface receives an indicator representing at least an identity of a therapeutic to be administered to the patient. A machine learning model determines from the indicator, the first set of patient data, and the second set of patient data if an alert should be provided to a user. The output device provides the alert to the user if the machine learning model determines that the alert should be provided.
Patent EP-3946085-A1 (EP)
Title: Surgical system and methods for stabilization and fixation of fractures, joints, and reconstructions
Inventor: CARLO ROBERT MICHAEL III
IPC: A61B17/58
Filed: 2020-04-02
Abstract: In various embodiments, a targeting guide is disclosed. The targeting guide includes a handle defining a targeting hole and a targeting tower configured to be coupled to the handle. The targeting tower defines at least a first guide hole and a second guide hole. Each of the first and second guide holes are sized and configured to receive a respective first guide pin and second guide pin therethrough. The first and second guide pins are configured to indicate alignment of a k-wire inserted through the targeting hole defined by the handle. Methods of using a targeting guide are also disclosed.
Patent EP-3896230-A1 (EP)
Inventor: OASA TAKAHISA
IPC: E02F3/43
Filed: 2020-04-02
Abstract: A lift force detection unit detects a lift force of a work machine. A control amount determination unit determines a control amount for the work machine based on a change amount of the detected lift force. A command output unit outputs, to an actuator driving the work machine, a control command according to the determined control amount.
Patent EP-4042753-A1 (EP)
Title: Sélection de plmn basée sur la géolocalisation d'un équipement utilisateur
Inventor: HIETALAHTI HANNU
IPC: H04W48/18
Filed: 2020-09-28
Abstract: Un procédé fait appel à l'étape suivante : lorsqu'un équipement utilisateur s'est déplacé d'un premier territoire géographique à un second territoire géographique, ce qui amène l'équipement utilisateur à se déplacer d'un premier réseau mobile terrestre public associé au premier territoire géographique à un second réseau mobile terrestre public associé au second territoire géographique.
Patent EP-4218271-A1 (EP)
Title: Non-ip header compression in broadcast sidelink communication
Inventor: ABBAS TAIMOOR
IPC: H04W4/44
Filed: 2020-10-12
Abstract: The invention relates to non-IP header compression in broadcast sidelink communication between client devices. A first client device compresses a broadcast sidelink packet according to a configuration for a compression profile by removing at least one non-IP header of the broadcast sidelink packet. The first client device transmits the compressed broadcast sidelink packet together with an indication of the compression profile. When a second client device receives the compressed broadcast sidelink packet, the second client device reconstructs the at least one non-IP header of the broadcast sidelink packet based on the configuration for the compression profile and the indicated compression profile. Thereby, the broadcast sidelink packet can be shortened such that transmission resources are saved and overall system capacity can be improved.
Patent EP-4048073-A1 (EP)
Title: Fibrinogène en tant qu'adjuvant pour agents antimicrobiens et thérapie
Inventor: KOOPMAN JACOB
IPC: A61K38/00
Filed: 2020-10-23
Abstract: La présente invention concerne une composition comprenant du fibrinogène pour augmenter la sensibilité de microorganismes pour un composé antimicrobien. L'invention peut être utilisée pour atténuer le problème de résistance aux antimicrobiens de biofilms ou d'agrégats microbiens, par exemple de biofilms microbiens sur des dispositifs médicaux, en particulier des dispositifs à demeure, ou dans des lits de plaie. Le dispositif ou le lit de plaie peut être (pré-)revêtu de fibrinogène pour augmenter la sensibilité aux antimicrobiens. L'agent antimicrobien peut être fourni séparément du fibrinogène ou conjointement avec celui-ci.
Patent EP-3964518-A1 (EP)
Inventor: DENG HAIBING
IPC: A61K31/7076
Filed: 2020-04-27
Abstract: A CD73 inhibitor having the structure represented by formula (I), a preparation method therefor and an application thereof. The series of compounds can be widely applied in the preparation of drugs for treating cancers or tumors that are at least partially mediated by CD73, autoimmune diseases and disorders and metabolic diseases, in particular drugs for treating melanoma, colon cancer, pancreatic cancer, breast cancer, prostate cancer, lung cancer, leukemia, brain tumor, lymphoma, ovarian cancer and Kaposi's sarcoma. A new generation of CD73 inhibitor drugs is expected to be developed.